Cidara Therapeutics Inc (NASDAQ:CDTX) price on Thursday, July 03, rose 1.90% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $48.78.
A look at the stock’s price movement, the close in the last trading session was $47.87, moving within a range at $46.39 and $49.37. The beta value (5-Year monthly) was 0.795. Turning to its 52-week performance, $56.83 and $10.14 were the 52-week high and 52-week low respectively. Overall, CDTX moved 109.36% over the past month.
Cidara Therapeutics Inc’s market cap currently stands at around $1.08 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-08.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CDTX is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend CDTX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CDTX’s current price about 40.64% and 79.64% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 77.98, while 7-day volatility ratio is 8.77% and 9.71% in the 30-day chart. Further, Cidara Therapeutics Inc (CDTX) has a beta value of 1.17. Analysts have given the company’s stock an average 52-week price target of $57, forecast between a low of $46 and high of $68. Looking at the price targets, the low is 5.7% off current price level while to achieve the yearly target high, price needs to move -39.4%. Nonetheless, investors will most likely welcome a -16.85% jump to $57 which is the analysts’ median price.
If we refocus on Cidara Therapeutics Inc (NASDAQ:CDTX), historical trading data shows that trading volumes averaged 2.35 over the past 10 days and 520.89K over the past 3 months. The company’s latest data on shares outstanding shows there are 22.12 million shares.
The 40.83% of Cidara Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 47.21% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.65 million on 2025-06-13, giving us a short ratio of 3.1. The data shows that as of 2025-06-13 short interest in Cidara Therapeutics Inc (CDTX) stood at 501.00001999999995 of shares outstanding, with shares short rising to 0.45 million registered in 2025-05-15. Current price change has pushed the stock 305.15% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CDTX stock continues to rise going into the next quarter.
